{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T16:46:47Z","timestamp":1758991607945},"reference-count":13,"publisher":"American Medical Association (AMA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Ophthalmol"],"published-print":{"date-parts":[[2020,1,1]]},"DOI":"10.1001\/jamaophthalmol.2019.4488","type":"journal-article","created":{"date-parts":[[2019,11,7]],"date-time":"2019-11-07T16:31:06Z","timestamp":1573144266000},"page":"14","source":"Crossref","is-referenced-by-count":14,"title":["Secondary 12-Month Ocular Outcomes of a Phase 1 Dosing Study of Bevacizumab for Retinopathy of Prematurity"],"prefix":"10.1001","volume":"138","author":[{"given":"Eric R.","family":"Crouch","sequence":"first","affiliation":[{"name":"Virginia Pediatric Eye Center, Virginia Beach"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond T.","family":"Kraker","sequence":"additional","affiliation":[{"name":"Jaeb Center for Health Research, Tampa, Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David K.","family":"Wallace","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Indiana University School of Medicine, Indianapolis"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan M.","family":"Holmes","sequence":"additional","affiliation":[{"name":"Mayo Clinic, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael X.","family":"Repka","sequence":"additional","affiliation":[{"name":"Wilmer Institute, Baltimore, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janine E.","family":"Collinge","sequence":"additional","affiliation":[{"name":"Dean A. McGee Eye Institute, University of Oklahoma, Oklahoma City"},{"name":"Now with Connecticut Children's Medical Center, Hartford, Connecticut"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Don L.","family":"Bremer","sequence":"additional","affiliation":[{"name":"Pediatric Ophthalmology Associates Inc, Columbus, Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael E.","family":"Gray","sequence":"additional","affiliation":[{"name":"Cincinnati Children\u2019s Hospital, Cincinnati, Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather A.","family":"Smith","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Indiana University School of Medicine, Indianapolis"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul G.","family":"Steinkuller","sequence":"additional","affiliation":[{"name":"Texas Children's Hospital, Houston"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"for the Writing Committee for Pediatric Eye Disease Investigator Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"issue":"2","key":"eoi190076r1","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.earlhumdev.2007.11.009","article-title":"Retinopathy of prematurity: a global perspective of the epidemics, population of babies at risk and implications for control.","volume":"84","author":"Gilbert","year":"2008","journal-title":"Early Hum Dev"},{"issue":"5","key":"eoi190076r2","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/S0161-6420(91)32247-4","article-title":"Laser photocoagulation for stage 3+ retinopathy of prematurity.","volume":"98","author":"McNamara","year":"1991","journal-title":"Ophthalmology"},{"issue":"6","key":"eoi190076r3","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.ophtha.2010.09.031","article-title":"Retinopathy of prematurity in infants weighing less than 500 grams at birth enrolled in the early treatment for retinopathy of prematurity study.","volume":"118","author":"Wheeler","year":"2011","journal-title":"Ophthalmology"},{"issue":"7","key":"eoi190076r4","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1056\/NEJMoa1007374","article-title":"Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity.","volume":"364","author":"Mintz-Hittner","year":"2011","journal-title":"N Engl J Med"},{"issue":"4","key":"eoi190076r5","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1136\/bjophthalmol-2013-304109","article-title":"Fluorescein angiographic observations of peripheral retinal vessel growth in infants after intravitreal injection of bevacizumab as sole therapy for zone I and posterior zone II retinopathy of prematurity.","volume":"98","author":"Tahija","year":"2014","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"eoi190076r6","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1001\/jamaophthalmol.2017.1055","article-title":"Assessment of lower doses of intravitreous bevacizumab for retinopathy of prematurity: a phase 1 dosing study.","volume":"135","author":"Wallace","year":"2017","journal-title":"JAMA Ophthalmol"},{"issue":"12","key":"eoi190076r7","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1016\/j.ophtha.2018.05.001","article-title":"A dosing study of bevacizumab for retinopathy of prematurity: late recurrences and additional treatments.","volume":"125","author":"Wallace","year":"2018","journal-title":"Ophthalmology"},{"issue":"12","key":"eoi190076r8","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1001\/archopht.121.12.1684","article-title":"Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial.","volume":"121","author":"Early Treatment For Retinopathy of Prematurity Cooperative Group","year":"2003","journal-title":"Arch Ophthalmol"},{"issue":"9","key":"eoi190076r9","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1038\/eye.2014.172","article-title":"Refractive errors after the use of bevacizumab for the treatment of retinopathy of prematurity: 2-year outcomes.","volume":"28","author":"Chen","year":"2014","journal-title":"Eye (Lond)"},{"issue":"6","key":"eoi190076r10","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.ajo.2013.01.014","article-title":"Intravitreal bevacizumab for retinopathy of prematurity: refractive error results.","volume":"155","author":"Harder","year":"2013","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"eoi190076r11","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1016\/j.ophtha.2014.12.017","article-title":"Outcomes after intravitreal bevacizumab versus laser photocoagulation for retinopathy of prematurity: a 5-year retrospective analysis.","volume":"122","author":"Hwang","year":"2015","journal-title":"Ophthalmology"},{"issue":"6","key":"eoi190076r12","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.jaapos.2011.07.017","article-title":"Prevalence and course of strabismus through age 6 years in participants of the Early Treatment for Retinopathy of Prematurity randomized trial.","volume":"15","author":"VanderVeen","year":"2011","journal-title":"J AAPOS"},{"issue":"6","key":"eoi190076r13","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1001\/archophthalmol.2010.72","article-title":"Final visual acuity results in the early treatment for retinopathy of prematurity study.","volume":"128","author":"Good","year":"2010","journal-title":"Arch Ophthalmol"}],"container-title":["JAMA Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/articlepdf\/2753931\/jamaophthalmology_crouch_2019_oi_190076.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,9]],"date-time":"2020-01-09T16:01:53Z","timestamp":1578585713000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/fullarticle\/2753931"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,1]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaophthalmol.2019.4488","relation":{},"ISSN":["2168-6165"],"issn-type":[{"type":"print","value":"2168-6165"}],"subject":[],"published":{"date-parts":[[2020,1,1]]}}}